Clinical Trial Update: An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038) [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial evaluating an investigational agent for complicated intra-abdominal infections and acute pelvic infectio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Intra-abdominal Infection
• Pelvic Infection

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Infections, Pelvic Infections | Phase 2 | Status: COMPLETED